ADVERTISEMENT
Latest Blogs, Articles, and More
The Art of Breaking Bad News
Ask a number of people how they received unsettling news about their cancer and most will remember in striking detail, but a doctor-led program aims to help physicians learn how to break bad news better. Will it help?
Keytruda Granted Breakthrough Status for Lung Cancer
The FDA has granted a breakthrough therapy designation to the immunotherapy drug Keytruda (pembrolizumab) for the treatment of patients with non-small cell lung cancer.
Integrated Care Model Emerges for Oncologic Emergencies
In September, The Ohio State University Comprehensive Cancer Center, collaborating with the Department of Emergency Medicine, opened a fully integrated cancer emergency department at the new James Cancer Hospital to care for patients who develop emergencies caused by their cancers.
Study Shows PARP Inhibitor Veliparib Could Help Patients with Squamous Cell Lung Cancer
Preliminary data from a phase 2 trial demonstrates that a combination of the PARP inhibitor veliparib and chemotherapy benefits patients with squamous cell non-small cell lung cancer.
Parenting with Advanced Cancer
Being a parent affects EVERY decision in my life, even the ones regarding my cancer care.
Special Feature


Nominate an extraordinary oncology nurse
Send us your essay nomination before February 20, 2015, for the chance to join CURE in honoring your oncology nurse! Submit your essay today!
[ Learn more ]
ADVERTISEMENT
ADVERTISEMENT
$auto_registration$